← All stocks

Attovia Therapeutics, Inc.

ATTO No buying or selling

CIK 0002058707 #5987 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

7 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Frazier Life Sciences XI, L.P.

10% owner

—

6,154,213

$104.62M

+8,068%

venBio Global Strategic Fund IV, L.P. entity

10% owner

—

4,181,367

$71.08M

—

GOLDMAN SACHS GROUP INC entity

Former 10% Owner

—

3,020,632

$51.35M

+2,755%

WALSH COLIN

Director

—

3,020,632

$51.35M

+2,755%

Redmile Group, LLC entity

10% owner

—

2,165,708

$36.82M

+176.6%

Deep Track Biotechnology Master Fund, Ltd. entity

10% owner

—

1,957,138

$33.27M

—

Sanofi

10% owner

—

1,082,855

$18.41M

—

No percentages here. Attovia Therapeutics, Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 6 Aug 2026